{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T13:07:49Z","timestamp":1681218469927},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00330-021-08445-0","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:04:11Z","timestamp":1642809851000},"page":"3269-3279","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CT findings and diagnostic performance of upper urinary tract carcinoma in situ"],"prefix":"10.1007","volume":"32","author":[{"given":"Hiroaki","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Sasaguri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafeal E.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,22]]},"reference":[{"key":"8445_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.juro.2016.03.194","volume":"197","author":"GP Redrow","year":"2017","unstructured":"Redrow GP, Guo CC, Brausi MA et al (2017) Upper urinary tract carcinoma in situ: current knowledge, future direction. J Urol 197:287\u2013295","journal-title":"J Urol"},{"key":"8445_CR2","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1464-410X.2010.09341.x","volume":"106","author":"E Pieras","year":"2010","unstructured":"Pieras E, Frontera G, Ruiz X, Vicens A, Ozonas M, Piza P (2010) Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 106:1319\u20131323","journal-title":"BJU Int"},{"key":"8445_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.urolonc.2010.01.001","volume":"30","author":"JC Wheat","year":"2012","unstructured":"Wheat JC, Weizer AZ, Wolf JS Jr et al (2012) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol 30:252\u2013258","journal-title":"Urol Oncol"},{"key":"8445_CR4","doi-asserted-by":"publisher","first-page":"547586","DOI":"10.1155\/2015\/547586","volume":"2015","author":"A Gillan","year":"2015","unstructured":"Gillan A, El-Mokadem I, Rai B et al (2015) Carcinoma in situ is significantly underdetected by prenephroureterectomy ureteroscopy in the management of upper tract urothelial cancers. Biomed Res Int 2015:547586","journal-title":"Biomed Res Int"},{"key":"8445_CR5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.eururo.2012.02.042","volume":"61","author":"E Xylinas","year":"2012","unstructured":"Xylinas E, Rink M, Margulis V et al (2012) Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. Eur Urol 61:1069\u20131070","journal-title":"Eur Urol"},{"key":"8445_CR6","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.eururo.2008.04.083","volume":"54","author":"JA Karam","year":"2008","unstructured":"Karam JA, Margulis V, Montorsi F et al (2008) Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy\u2013results from a multicenter study. Eur Urol 54:961\u2013963","journal-title":"Eur Urol"},{"key":"8445_CR7","doi-asserted-by":"crossref","unstructured":"Jinzaki M, Matsumoto K, Kikuchi E et al (2011) Comparison of CT urography and excretory urography in the detection and localization of urothelial carcinoma of the upper urinary tract.\u00a0AJR Am J Roentgenol\u00a0196:1102\u20131109","DOI":"10.2214\/AJR.10.5249"},{"key":"8445_CR8","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/j.1464-410X.2007.06766.x","volume":"99","author":"NC Cowan","year":"2007","unstructured":"Cowan NC, Turney BW, Taylor NJ, McCarthy CL, Crew JP (2007) Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour. BJU Int 99:1363\u20131370","journal-title":"BJU Int"},{"key":"8445_CR9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2214\/AJR.10.6377","volume":"197","author":"M Kupershmidt","year":"2011","unstructured":"Kupershmidt M, Margolis M, Jang HJ, Massey C, Metser U (2011) Evaluation of upper urinary tract tumors with portal venous phase MDCT: a case-control study. AJR Am J Roentgenol 197:424\u2013428","journal-title":"AJR Am J Roentgenol"},{"key":"8445_CR10","doi-asserted-by":"publisher","first-page":"W320","DOI":"10.2214\/AJR.14.14075","volume":"205","author":"M Takeuchi","year":"2015","unstructured":"Takeuchi M, Konrad AJ, Kawashima A, Boorjian SA, Takahashi N (2015) CT urography for diagnosis of upper urinary tract urothelial carcinoma: are both nephrographic and excretory phases necessary? AJR Am J Roentgenol 205:W320-327","journal-title":"AJR Am J Roentgenol"},{"key":"8445_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1148\/radiol.12111623","volume":"264","author":"U Metser","year":"2012","unstructured":"Metser U, Goldstein MA, Chawla TP, Fleshner NE, Jacks LM, O\u2019Malley ME (2012) Detection of urothelial tumors: comparison of urothelial phase with excretory phase CT urography\u2013a prospective study. Radiology 264:110\u2013118","journal-title":"Radiology"},{"key":"8445_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ejrad.2008.10.026","volume":"73","author":"K Chlapoutakis","year":"2010","unstructured":"Chlapoutakis K, Theocharopoulos N, Yarmenitis S, Damilakis J (2010) Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: systematic review and meta-analysis. Eur J Radiol 73:334\u2013338","journal-title":"Eur J Radiol"},{"key":"8445_CR13","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.juro.2010.02.028","volume":"183","author":"LJ Wang","year":"2010","unstructured":"Wang LJ, Wong YC, Ng KF, Chuang CK, Lee SY, Wan YL (2010) Tumor characteristics of urothelial carcinoma on multidetector computerized tomography urography. J Urol 183:2154\u20132160","journal-title":"J Urol"},{"key":"8445_CR14","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.2214\/ajr.184.6.01841873","volume":"184","author":"EM Caoili","year":"2005","unstructured":"Caoili EM, Cohan RH, Inampudi P et al (2005) MDCT urography of upper tract urothelial neoplasms. AJR Am J Roentgenol 184:1873\u20131881","journal-title":"AJR Am J Roentgenol"},{"key":"8445_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/rpd\/nch512","volume":"114","author":"DP Chakraborty","year":"2005","unstructured":"Chakraborty DP (2005) Recent advances in observer performance methodology: jackknife free-response ROC (JAFROC). Radiat Prot Dosimetry 114:26\u201331","journal-title":"Radiat Prot Dosimetry"},{"key":"8445_CR16","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1118\/1.1884766","volume":"32","author":"B Zheng","year":"2005","unstructured":"Zheng B, Chakraborty DP, Rockette HE, Maitz GS, Gur D (2005) A comparison of two data analyses from two observer performance studies using Jackknife ROC and JAFROC. Med Phys 32:1031\u20131034","journal-title":"Med Phys"},{"key":"8445_CR17","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.acra.2006.06.016","volume":"13","author":"DP Chakraborty","year":"2006","unstructured":"Chakraborty DP (2006) Analysis of location specific observer performance data: validated extensions of the jackknife free-response (JAFROC) method. Acad Radiol 13:1187\u20131193","journal-title":"Acad Radiol"},{"key":"8445_CR18","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2214\/AJR.09.4177","volume":"195","author":"AD Xu","year":"2010","unstructured":"Xu AD, Ng CS, Kamat A, Grossman HB, Dinney C, Sandler CM (2010) Significance of upper urinary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms. AJR Am J Roentgenol 195:959\u2013965","journal-title":"AJR Am J Roentgenol"},{"key":"8445_CR19","doi-asserted-by":"publisher","first-page":"W337","DOI":"10.2214\/AJR.09.4147","volume":"195","author":"CA Sadow","year":"2010","unstructured":"Sadow CA, Wheeler SC, Kim J, Ohno-Machado L, Silverman SG (2010) Positive predictive value of CT urography in the evaluation of upper tract urothelial cancer. AJR Am J Roentgenol 195:W337-343","journal-title":"AJR Am J Roentgenol"},{"key":"8445_CR20","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/s00330-008-1228-y","volume":"19","author":"N Takahashi","year":"2008","unstructured":"Takahashi N, Kawashima A, Glockner JF, Hartman RP, Kim B, King BF (2008) MR urography for suspected upper tract urothelial carcinoma. Eur Radiol 19:912\u2013923","journal-title":"Eur Radiol"},{"key":"8445_CR21","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s11604-019-00889-1","volume":"37","author":"K Yoshida","year":"2019","unstructured":"Yoshida K, Hamaoka M, Kobayashi S et al (2019) Renal pelvic and ureteral wall thickening in renal cell carcinoma: prevalence, cause, and clinical significance. Jpn J Radiol 37:832\u2013840","journal-title":"Jpn J Radiol"},{"key":"8445_CR22","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/j.juro.2006.07.162","volume":"176","author":"MC Schumacher","year":"2006","unstructured":"Schumacher MC, Scholz M, Weise ES, Fleischmann A, Thalmann GN, Studer UE (2006) Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder? J Urol 176:2409\u20132413 (discussion 2413)","journal-title":"J Urol"},{"key":"8445_CR23","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1002\/cncr.22238","volume":"107","author":"GV Raj","year":"2006","unstructured":"Raj GV, Tal R, Vickers A et al (2006) Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer. Cancer 107:2167\u20132172","journal-title":"Cancer"},{"key":"8445_CR24","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1111\/bju.12344","volume":"113","author":"AN Hoang","year":"2014","unstructured":"Hoang AN, Agarwal PK, Walton-Diaz A et al (2014) Clinical significance of ureteric \u2018skip lesions\u2019 at the time of radical cystectomy: the M.D. Anderson experience and literature review. BJU Int 113:E28-33","journal-title":"BJU Int"},{"key":"8445_CR25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0022-5347(01)64312-X","volume":"158","author":"DA Silver","year":"1997","unstructured":"Silver DA, Stroumbakis N, Russo P, Fair WR, Herr HW (1997) Ureteral carcinoma in situ at radical cystectomy: does the margin matter? J Urol 158:768\u2013771","journal-title":"J Urol"},{"key":"8445_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0090-4295(96)00571-7","volume":"49","author":"E Solsona","year":"1997","unstructured":"Solsona E, Iborra I, Ricos JV, Dumont R, Casanova JL, Calabuig C (1997) Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis): its impact on management. Urology 49:347\u2013352","journal-title":"Urology"},{"key":"8445_CR27","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.juro.2013.05.020","volume":"190","author":"IA Sternberg","year":"2013","unstructured":"Sternberg IA, Keren Paz GE, Chen LY et al (2013) Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer. J Urol 190:1187\u20131191","journal-title":"J Urol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-08445-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-021-08445-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-08445-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T15:19:20Z","timestamp":1650899960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-021-08445-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,22]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["8445"],"URL":"https:\/\/doi.org\/10.1007\/s00330-021-08445-0","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,22]]},"assertion":[{"value":"4 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Naoki Takahashi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 diagnostic or prognostic study\u2022 performed at single institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}